Communication
Green Chemistry
2
3
S. Riela, M. Massaro, C. G. Colletti, A. Bommarito,
C. Giordano, S. Milioto, R. Noto, P. Poma and G. Lazzara,
Int. J. Pharm., 2014, 475, 613–623.
P. Sambasiva Rao, C. Kurumurthy, B. Veeraswamy,
G. Santhosh Kumar, Y. Poornachandra, C. Ganesh Kumar,
S. B. Vasamsetti, S. Kotamraju and B. Narsaiah, Eur. J. Med.
Chem., 2014, 80, 184–191.
Scheme 1 Selective N-1 methylation of 16.
4
5
Y.-C. Duan, Y.-C. Ma, E. Zhang, X.-J. Shi, M.-M. Wang,
X.-W. Ye and H.-M. Liu, Eur. J. Med. Chem., 2013, 62, 11–19.
P. Singh, R. Raj, V. Kumar, M. P. Mahajan, P. M. S. Bedi,
T. Kaur and A. K. Saxena, Eur. J. Med. Chem., 2012, 47, 594–
bond angle compared to the remaining nitrogen atoms.
Correspondingly, we obtained the crystal structure of 16 and
were able to assign the position of the N bearing H as 1H
based on both the bond angles of nitrogens in the triazole
ring as well as the hydrogen bonding patterns in the unit cell
600.
6
7
T. Phuong, T. Khac-Minh, N. T. Van Ha and H. T. Ngoc
Phuong, Bioorg. Med. Chem. Lett., 2004, 14, 653–656.
E. Rodríguez-Fernández, J. L. Manzano, J. J. Benito,
R. Hermosa, E. Monte and J. J. Criado, J. Inorg. Biochem.,
(Fig. 3-right). Moreover, Wipf et al. have reported that the
methylation of the N-2 tautomer of 16 affords the formation of
both N-2 and N-1 methylate products in a 76 : 24 ratio respect-
5
9
ively. However, interestingly in our case the methylation of
6 resulted in the regioselective N-1 methylation (17) as
2005, 99, 1558–1572.
1
8
9
C. Lass-Flörl, Drugs, 2011, 71, 2405–2419.
L. R. Peyton, S. Gallagher and M. Hashemzadeh, Drugs
Today Barc. Spain 1998, 2015, 51, 705–718.
observed in the crude NMR of the reaction mixture (see the
ESI†) without any traces of N-2 (Scheme 1). While all other syn-
thesized 1,2,3-triazoles in this work show rapid tautomeriza-
tion at room temperature, to the best of our knowledge, com-
pound 16 is a rare case that can be obtained exclusively as a
10 R. P. Tripathi, A. K. Yadav, A. Ajay, S. S. Bisht,
V. Chaturvedi and S. K. Sinha, Eur. J. Med. Chem., 2010, 45,
142–148.
1
H tautomer through the presented protocol.
1
1 M. S. Costa, N. Boechat, É. A. Rangel, F. de C. da Silva,
A. M. T. de Souza, C. R. Rodrigues, H. C. Castro,
I. N. Junior, M. C. S. Lourenço, S. M. S. V. Wardell and
V. F. Ferreira, Bioorg. Med. Chem., 2006, 14, 8644–8653.
2 R. V. Somu, H. Boshoff, C. Qiao, E. M. Bennett, C. E. Barry
and C. C. Aldrich, J. Med. Chem., 2006, 49, 31–34.
3 C. P. Kaushik, K. Kumar, S. K. Singh, D. Singh and S. Saini,
Arabian J. Chem., 2016, 9, 865–871.
4 H.-Z. Zhang, J.-J. Wei, K. V. Kumar, S. Rasheed and
C.-H. Zhou, Med. Chem. Res., 2015, 24, 182–196.
Finally, it has been reported that some of the synthesized
triazoles in this work show promising biological activities as
single molecules. For instance, compound 1 shows stronger
indoleamine 2,3-dioxygenase (IDO) inhibitory activity when
1
1
1
1
6
0
compared to the most commonly used inhibitor 1-MT, while
6
1
6
and 13 respectively show promising metalloenzyme and
6
2
viral polymerase inhibitory effects. We believe that our work
presents a green and more biologically suitable method to
synthesize such valuable compounds. Our method is not only
catalyst-free, additive-free, and solvent-free, but also provides
an atom economical, safer, and more convenient route to syn-
thesize 1,2,3-triazoles. The simple work-up and purification
procedure along with its scalability makes this method a
potent green route for synthesizing potentially pharmaceuti-
cally valuable compounds on a practical scale without any
metal contamination.
5 U. F. Röhrig, L. Awad, A. Grosdidier, P. Larrieu,
V. Stroobant, D. Colau, V. Cerundolo, A. J. G. Simpson,
P. Vogel, B. J. Van den Eynde, V. Zoete and O. Michielin,
J. Med. Chem., 2010, 53, 1172–1189.
1
6 L. S. Kallander, Q. Lu, W. Chen, T. Tomaszek, G. Yang,
D. Tew, T. D. Meek, G. A. Hofmann, C. K. Schulz-Pritchard,
W. W. Smith, C. A. Janson, M. D. Ryan, G.-F. Zhang,
K. O. Johanson, R. B. Kirkpatrick, T. F. Ho, P. W. Fisher,
M. R. Mattern, R. K. Johnson, M. J. Hansbury,
J. D. Winkler, K. W. Ward, D. F. Veber and S. K. Thompson,
J. Med. Chem., 2005, 48, 5644–5647.
Conflicts of interest
There are no conflicts to declare.
1
7 I. S. Bennett, G. Brooks, N. J. P. Broom, S. H. Calvert,
K. Coleman and I. François, J. Antibiot., 1991, 44, 969–978.
8 C.-H. Zhou and Y. Wang, Curr. Med. Chem., 2012, 19, 239–
1
Acknowledgements
280.
1
2
2
2
2
9 A. Michael, J. Prakt. Chem., 1893, 48, 94–95.
Financial support by the Loker Hydrocarbon Research
Instituted is gratefully acknowledged.
0 R. Huisgen, Angew. Chem., Int. Ed. Engl., 1963, 2, 633–645.
1 R. Huisgen, Angew. Chem., Int. Ed. Engl., 1963, 2, 565–598.
2 R. Huisgen, Angew. Chem., Int. Ed. Engl., 1968, 7, 321–328.
3 R. B. Woodward and R. Hoffmann, Angew. Chem., Int. Ed.
Engl., 1969, 8, 781–853.
Notes and references
1
P. Yadav, K. Lal, A. Kumar, S. K. Guru, S. Jaglan and 24 H. C. Kolb, M. G. Finn and K. B. Sharpless, Angew. Chem.,
S. Bhushan, Eur. J. Med. Chem., 2017, 126, 944–953. Int. Ed., 2001, 40, 2004–2021.
Green Chem.
This journal is © The Royal Society of Chemistry 2018